StonvexLoading…
StonvexStonvexStonvexCore line items from SN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $1.41B | $6.40B | $1.22B | $5.53B |
Operating Income | $164.53M | $920.28M | $144.95M | $644.16M |
Net Income | $121.46M | $701.37M | $117.83M | $438.70M |
EPS (Diluted) | $0.85 | $4.94 | $0.83 | $3.11 |
Total Assets | $5.02B | $5.35B | Not available | $4.39B |
Total Liabilities | $2.26B | $2.67B | Not available | $2.46B |
Cash & Equivalents | $511.77M | $777.29M | $224.70M | $363.67M |
Free Cash Flow OCF − CapEx | $-190.20M | $488.05M | $-87.52M | $308.93M |
Shares Outstanding | 141.71M | 141.16M | 142.18M | 140.35M |